DPP-4 inhibitors: focus on safety
Year: 2014
Type: review
Source: Expert Opinion on Drug Safety
Authors: Sri Harsha Tella, Marc S Rendell
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: DPP-4 inhibitors, drug safety, saxagliptin, linagliptin, alogliptin, sitagliptin, vildagliptin, incretins, drug interactions, cytochrome P450 metabolism, congestive heart failure, pancreatitis, pancreatic cancer, cutaneous adverse events, anti-hyperglycemic agents, sulfonylureas, glimepiride, renal dysfunction
Open Access status: closed
OpenAlex ID: W2085790896
